clairop

How Long Does an IBS Flare Up Last? Honest Answer

No study has measured how long an IBS flare lasts, because nobody agreed a definition. What the evidence does show, and what actually decides your duration.

Clairop Team28 min read

Photo: Louis Hansel / Unsplash

The short answer

There is no published average for IBS flare duration, because a flare has never been defined well enough to measure. The nearest real data comes from daily diaries, where pain came in many short episodes rather than one long block. What decides your duration is whether the trigger is still running, whether it started with an infection, and whether you have a baseline to return to.

Here is the honest answer, and it is not the one the search results give you: no study has ever measured how long an IBS flare lasts. Not because researchers have not got round to it, but because "flare" has never been defined precisely enough to time. There is no start line and no finish line, so there is nothing to put a stopwatch on.

That matters, because almost every page ranking for this question quotes a confident figure. Two to four days. A few hours to a few weeks. One popular claim even puts a percentage on it. None of them cite a study that measured flare duration, because none exists. The numbers are estimates that have been copied between health sites until they acquired the texture of fact.

What we can do instead is far more useful than a fake average. We can tell you what the closest real data looks like, what actually determines whether your episode runs for two days or two months, which durations have genuinely been measured, and at what point a long flare stops being a flare and becomes something a doctor should look at.

The short answer: most bad patches run days, but that is description, not data

If you want a one-line answer to take away: most people with IBS describe bad patches that run somewhere between a day and a fortnight, with a long tail of people reporting weeks or months, and a significant group who say they do not have flares at all because their symptoms never stop.

That is an accurate summary of what people report. It is not a measurement. The distinction matters because the two are constantly confused online, and because the second question people actually want answered is "so when will mine end?", which a population average could never tell you anyway.

The three threads in r/ibs that ask this question most directly illustrate the spread perfectly. Across them, replies included one day, two to three days, five days, ten days, twelve hours "almost to the exact second", two weeks, four weeks, five weeks, three months, six months and a year (r/ibs, r/ibs, r/ibs). Several of the most upvoted replies were versions of the same objection: that if a flare means any day that is not normal, then their life is one continuous flare and the question has no answer.

They are describing lived experience, not evidence, and we treat it as such throughout this article. But the shape of that spread is itself informative. A condition with a characteristic episode length does not produce answers ranging across three orders of magnitude.

Why there is no published average, and how to spot a page that invented one

The reason is structural, and once you see it you cannot unsee it. IBS research does not measure flares. It measures weeks.

Rome IV, the criteria that define IBS for research and increasingly in clinic, requires recurrent abdominal pain on average at least one day a week over the last three months, with symptom onset at least six months before diagnosis (Mearin 2016). Read that again: the definition is built out of a three-month average of how many days a week hurt. There is no concept of an episode in it at all. Nothing in the diagnostic framework says when one flare ends and the next begins.

Treatment trials inherit the same structure. The Rome Foundation's guidance on trial design recommends that the primary analysis be the proportion of patients in each arm meeting a responder definition or a prespecified clinically meaningful change in a patient-reported outcome (Irvine 2016). So a trial asks "was this person a responder over 12 weeks?", never "how long did their episodes last?" Even the standard severity instrument, the IBS Severity Scoring System, scores the last ten days as a block and treats a 50-point change as a reliable improvement (Francis 1997). It is a dial, not a stopwatch.

The closest thing to real data: 63 people, 42 days of diaries

The one study we found that recorded IBS symptoms with enough granularity to say anything about episode length was not designed to answer this question at all.

In 1998, researchers in the primary care catchment of the University Hospital of Linköping in Sweden asked 80 consecutive patients meeting Rome criteria to record their symptoms daily for six weeks. Sixty-three finished. Of those, 59 recorded an average of 29 separate pain periods across 24 days with pain during the six weeks (Ragnarsson 1998).

Sit with those two numbers, because they are the single most useful thing in this article.

Twenty-four days with pain out of 42 means pain on well over half of all days. But twenty-nine distinct pain periods across those 24 days means pain arrived and departed roughly once or twice on each painful day. It was not one long block. It was a repeating series of short waves, most of them resolving the same day, separated by intervals of feeling all right.

That is a completely different picture from "a flare lasts three days". It suggests that what people experience as a multi-day flare is often a cluster of short episodes arriving close together, and that the thing which changes during a bad patch is the frequency of episodes, not the length of one.

The study reported something else worth pulling out. Bowel symptoms varied within fortnightly periods but not between them. In other words, if you averaged each person's symptoms over two weeks, the fortnights looked much the same as each other. All the movement was inside the fortnight.

The caveats are real: 63 people, one Swedish centre, 1998, Rome criteria that have been revised twice since, and a study whose stated purpose was to examine the relationship of pain to eating and defaecation rather than to time episodes. We are reading a secondary finding. But a secondary finding from real daily records beats a confident number with nothing behind it.

You are probably asking four different questions at once

Part of why this question is so unsatisfying to search is that "how long does a flare last" bundles four questions with four different answers and four different timescales.

What you are really askingRealistic timescaleWhat the evidence says
How long until this attack passes?HoursPost-meal symptoms in IBS typically rise and fall within hours, covered in our timeline of post-meal reactions
How long until this bad patch passes?Days to weeksNo measured data. Diary records suggest clusters of short episodes rather than one long one
How long until I am back to normal for me?WeeksDepends entirely on whether you have a stable baseline to return to
Will I have IBS forever?YearsLong-term follow-up shows roughly 30 to 50 percent unchanged, 2 to 18 percent worse, the rest improved or symptom-free

That last row comes from a systematic review of 14 longitudinal studies of IBS patients in clinic settings. Across long-term follow-up, 2 to 18 percent of people developed worse symptoms, approximately 30 to 50 percent had unchanged symptoms, and the remainder either improved or had their symptoms disappear. The same review found that only 2 to 5 percent were later diagnosed with a different organic gastrointestinal disorder after six months to six years of follow-up (El-Serag 2004).

That second finding is quietly reassuring for anyone convinced a long flare must mean something was missed. It is not nothing, and it is a reason to get a long episode checked. But the base rate is low.

What actually determines how long yours lasts

Since there is no average to apply to you, the productive question is what is keeping this one going. Six things account for most of the variation in what people describe, and for each there is either evidence or a clear reason to look at it.

1. Whether the driver has actually stopped. This is the big one. A flare tends to last as long as the thing feeding it. If the stressful period is ongoing, the diet has not genuinely changed, or you are still sleeping badly, there is no reason for symptoms to resolve on a schedule. Our guide to stress and IBS flares covers the mechanism in depth.

2. Sleep, in a way that is measurable night to night. In a study of 82 women with IBS and 35 controls using daily diaries across two menstrual cycles, poorer-than-average sleep on one night was associated with higher-than-average gastrointestinal symptoms the following day. The within-person effect was small but statistically significant in the IBS group and not in controls, and it barely changed when daily stress and psychological distress were controlled for (Jarrett 2000). The population here is women with IBS specifically. A run of bad nights is a plausible reason a flare keeps renewing itself each morning.

3. Whether it started with an infection. This changes the answer more than anything else, and it is the one timescale that has genuinely been measured. See the next section.

4. Your subtype, and whether it is shifting. In a study of 317 women with IBS followed with diary cards over a year, more than 75 percent changed subtype at least once, and mixed-type IBS was the least stable, with half moving out of it within 12 weeks (Drossman 2005). A "flare" that swings from diarrhoea to constipation and back, which several people in the r/ibs threads described, is a recognised pattern rather than a sign of something unusual. Our guide to the difference between IBS-D and IBS-C covers subtype instability in full.

5. Whether you have a baseline to return to. If your usual state is three loose stools a day, "back to normal" arrives much sooner than if your usual state is one formed stool a day. This is the single most common source of confusion in the community threads and it is not a semantic quibble: it changes what counts as the end of the episode.

6. How much attention the symptoms are getting. Not because it is in your head, but because the gut-brain pathway is genuinely two-directional. More on that below.

If it started with a stomach bug, this is the one duration with real numbers

Post-infectious IBS is the exception to everything above, because a whole cohort's worth of people had a dated start point, which makes duration measurable.

After a municipal water supply in Walkerton, Ontario was contaminated with E. coli O157:H7 and Campylobacter jejuni in May 2000, researchers followed thousands of residents for years. Two years after the outbreak, IBS meeting Rome I criteria was present in 36.2% of people with clinically suspected gastroenteritis and 27.5% of those with self-reported gastroenteritis, against 10.1% of controls who had not been ill (Marshall 2006).

Then they kept going. Among the 742 eligible people who had suffered acute gastroenteritis during the outbreak, IBS prevalence fell from 28.3% at two to three years to 15.4% at eight years, though it remained significantly higher than in controls (odds ratio 3.12, 95% CI 1.99 to 5.04). Risk factors for still having it at eight years included female sex, younger age, prior anxiety or depression, and fever or weight loss during the original illness (Marshall 2010).

Read that as a duration statement and it says something genuinely useful: post-infectious IBS resolves in roughly half of people within eight years, but slowly, and not in everyone. That is not the answer anyone wants when they are three weeks into their first episode, but it is real, it is measured, and it is the opposite of the "this is permanent now" story people tell themselves at 3am.

The same pattern shows up after other infections. A meta-analysis of 15 studies and 1,218 patients found a pooled post-infection IBS prevalence of 21.1% after Clostridioides difficile infection, though with very high heterogeneity between studies, which the authors report explicitly (Saha 2022). After COVID-19, a meta-analysis of 13 studies covering 3,950 patients and 991 controls found IBS in 7.2% of people who had had COVID-19 against 4.9% of healthy controls (Mathur 2024).

If your current episode started with a documented bout of gastroenteritis, the honest framing is not "how long will this flare last" but "this may be a slow recovery measured in months to years, with good odds of improvement". That is a different conversation with a doctor, and a different set of expectations.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Join the waitlist

Does worrying about the flare make it last longer?

This question comes up in almost every duration thread, usually phrased apologetically, and it deserves a straight answer: the evidence points towards yes, without proving it, and the mechanism is not "it is all in your head".

The strongest evidence on direction comes from a 12-year prospective population study of 1,775 Australians, of whom 1,002 completed follow-up. Among people free of a functional gastrointestinal disorder at baseline, higher anxiety at baseline independently predicted developing one 12 years later. But among people who did not have elevated anxiety or depression at baseline, having gut symptoms predicted higher anxiety and depression at follow-up. The authors concluded the brain-gut pathway runs in both directions (Koloski 2012).

So a flare that has been running for three weeks is plausibly generating anxiety, and that anxiety is plausibly feeding back into the symptoms. Neither half of that loop is imaginary.

The specific cognitive pattern with the best evidence is pain catastrophising: the tendency to magnify, ruminate on and feel helpless about pain. In a cross-sectional study of 920 participants in Mexico, clinically significant pain catastrophising was present in 22.5% of people with IBS versus 11% of healthy controls, and it scaled hard with symptom severity: 52.2% of those with severe symptoms, 25.3% with moderate, 14.7% with mild (Priego-Parra 2025). That is cross-sectional, so it cannot tell you which came first.

A trial of cognitive behavioural therapy in 436 people with Rome III IBS gets closer to causality. Reductions in pain catastrophising during treatment mediated improvements in symptom severity, global improvement and quality of life (Roger 2023). Mediation analysis is still not proof of cause, and the authors themselves raise the possibility that catastrophising change is a non-specific effect that shows up across very different treatments, but it is a reasonable basis for saying that how you relate to the symptoms is part of the picture and is modifiable.

None of which means you can end a flare by thinking correctly about it. It means that a flare which has become the centre of your attention has an extra thing keeping it going, and that is worth naming rather than feeling guilty about.

How long after changing your diet should a flare settle?

Longer than most people give it. A few days is almost never enough to judge.

In the randomised crossover trial that established low FODMAP against a typical Australian diet, participants ate each diet for 21 days with a washout of at least 21 days between, with nearly all food provided. Overall gastrointestinal symptom scores were lower on the low FODMAP diet (22.8mm on a 100mm scale, 95% CI 16.7 to 28.8) than on the Australian diet (44.9mm, 95% CI 36.6 to 53.1) (Halmos 2014).

In a Swedish multi-centre randomised trial of 75 people, low FODMAP was compared against traditional IBS dietary advice, which emphasises regular meal patterns, avoiding large meals and reducing fat, insoluble fibre, caffeine and gas-producing foods. Both groups ran for four weeks. Symptom severity fell in both groups, and the trial found no evidence that low FODMAP was superior to the traditional advice (Bohn 2015). That is worth knowing before you commit to the harder option.

The American College of Gastroenterology recommends a limited trial of a low FODMAP diet to improve global symptoms in IBS (Lacy 2021), and the word "limited" is doing real work. The restriction phase is meant to be short and structured, followed by systematic reintroduction, ideally with a dietitian, and it is not a diet to stay on. We cover the timings in how long you should do the low FODMAP diet and the process in how to reintroduce foods afterwards.

There is a hard truth inside this for anyone mid-flare. The middle of a bad patch is the worst possible time to start learning which foods you react to, because everything provokes symptoms when the gut is already sensitised. Our guide to what to eat during an IBS flare makes the case for changing how you eat before changing what you eat.

How long do treatments take to work? A timing table

This is not medical advice and nothing here is a recommendation to start, stop or change any treatment, which is a conversation for you and your doctor. It is a set of realistic timescales, so you know whether it is too early to judge.

ApproachTimescale used in trialsWhat the trial actually found
Peppermint oil, antispasmodics, tricyclics4 to 12 weeksPeppermint oil ranked first for global symptom improvement and tricyclics second, but no active treatment was significantly better than any other on direct or indirect comparison, and only 13 of 51 trials were at low risk of bias (Black 2020)
Low-dose amitriptyline in primary care6 months, with titration over 3 weeksMean IBS-SSS difference of -27.0 points versus placebo at 6 months (95% CI -46.9 to -7.10, p=0.0079). Publicly funded by the UK NIHR (Ford 2023)
Rifaximin for IBS without constipation2 weeks of treatment, 10 weeks of follow-upSignificantly more patients reported adequate relief of global symptoms than on placebo. Industry-sponsored, with authors including employees of and consultants to the manufacturer (Pimentel 2011)
Increased physical activity12 weeksMedian IBS-SSS change of -51 in the activity group versus -5 in controls (p=0.003) in 75 completers (Johannesson 2011)
Gut-directed hypnotherapyCourse of treatment, then years of follow-up71% of 204 patients responded initially; of those, 81% maintained improvement at up to six years, with no significant difference in symptom scores at 1, 2, 3, 4 or 5+ years (Gonsalkorale 2003)

Two caveats that apply across the whole table. The hypnotherapy study was uncontrolled and used retrospective self-assessment of responder status, so it tells you about durability among people who responded, not about efficacy against a sham. And every one of these numbers sits on top of a large placebo response: a meta-analysis of 73 randomised trials found a pooled placebo response rate of 27.3% on global improvement and 34.4% on abdominal pain (Bosman 2021). Roughly a third of people improve on nothing at all over a trial period, which is also, incidentally, another reason that bad patches appear to end when you try something.

When "flare" is the wrong word for what is happening

A large fraction of the replies in the duration threads were not answers. They were corrections. People saying, in various ways, that they do not have flares because they have never stopped.

One of the most upvoted replies in an r/ibs duration thread put it bluntly: if a flare is defined as anything other than normal, their life would be one never-ending flare, so they had redefined a flare privately as a particularly violent episode (r/ibs). Others described two to eight loose stools daily, every day, with no episodic structure at all.

If that is you, the duration question genuinely does not apply, and asking it will keep producing answers that do not fit. What you have is a baseline problem, not an episode problem, and the two need different responses. A flare is something to ride out and learn from. An unacceptable baseline is something to take back to a clinician and treat. Our guide to knowing whether your IBS is flaring up walks through how to build a personal baseline so the word starts meaning something again, and why IBS comes and goes covers the longer waves.

The four-week line: when a long flare stops being a flare

This is the most actionable thing in this article, and almost nobody writing about flare duration mentions it.

British Society of Gastroenterology guidance defines chronic diarrhoea pragmatically as a persistent alteration from the norm, with stool consistency between Bristol types 5 and 7 and increased frequency, lasting more than four weeks (Arasaradnam 2018). Past that line, the clinical question is no longer "how do I manage this flare" but "what is causing chronic diarrhoea", and that has a defined set of things to check.

This reframe matters because the search query itself encourages waiting. Someone six weeks into an episode reads that flares can last weeks to months, concludes they are within normal range, and waits another six. Meanwhile there are specific, testable explanations for a bad patch that will not end:

  • Coeliac disease. A meta-analysis of 14 studies and 4,204 individuals found biopsy-proved coeliac disease in a pooled 4.1% of people meeting symptom criteria for IBS (95% CI 1.9 to 7.0) (Ford 2009). The ACG suggests serologic testing to rule out coeliac disease in people with IBS and diarrhoea (Lacy 2021).
  • Bile acid malabsorption. A systematic review of 18 studies and 1,223 patients found that across 17 studies, 32% of people with an IBS-D diagnosis had moderate bile acid malabsorption on SeHCAT testing (95% CI 29 to 35), and 10% had severe malabsorption. The authors argued explicitly that IBS guidelines needed revising so clinicians would recognise it (Wedlake 2009). Availability of SeHCAT varies a lot by country.
  • Inflammatory bowel disease. The ACG suggests checking faecal calprotectin in people with suspected IBS and diarrhoea to rule out IBD (Lacy 2021).
  • Small intestinal bacterial overgrowth, which overlaps confusingly with IBS-D and is covered in our guide to SIBO versus IBS symptoms.

One long post in r/ibs described fifteen years of daily morning and post-meal diarrhoea with constant urgency, repeatedly attributed to IBS and to stress, before bile acid malabsorption was eventually identified (r/ibs). That is one person's account rather than data, and we cannot verify any of it. We include it because it is the human version of the Wedlake finding, and because the timeline in it is what "waiting out a long flare" can look like in practice.

The counterweight is worth stating too, so this does not read as an invitation to demand every test. A systematic review of diagnostic testing found that among patients meeting symptom-based criteria for IBS, the pretest probability of inflammatory bowel disease, colorectal cancer or infectious diarrhoea was less than 1%, and routinely recommended tests rarely found organic disease. Coeliac disease was the exception, at about ten times the general population prevalence (Cash 2002). Most long flares are long flares. The point is that four weeks is the threshold at which someone should be looking, not the threshold at which you should panic.

A worked example: same six weeks, two different answers

Here is how the zoom-level problem plays out in practice. Imagine two people who both log symptoms daily for six weeks and both ask how long their flare lasted.

Person A has a clear baseline: one or two formed stools most days, occasional mild bloating. In week three they have four consecutive days of cramping, urgency and Bristol 6 stools after a stressful work deadline, then two mixed days, then back to formed stools and no pain. Their answer is straightforward: about six days, trigger identifiable, resolved.

Person B logs two to five loose stools every day for all six weeks, with pain on most of them. Within that, there are two stretches of three days where the pain is much worse and they cannot leave the house. Asked how long their flare lasted, they can honestly say six weeks, or they can say three days twice. Both answers describe the same log.

Person A needs a duration answer. Person B needs a baseline conversation, because at Bristol 5 to 7 with increased frequency for more than four weeks they are in chronic diarrhoea territory by the BSG definition (Arasaradnam 2018), whatever label has been applied.

The practical lesson: before you can answer how long a flare lasts, you have to be able to see your non-flare. That is what six to eight weeks of consistent logging gives you, and it is the reason keeping a food and symptom diary is worth the effort even when it feels like bookkeeping. If you would rather not run it on paper, Clairop logs a bowel movement in one tap and produces a report you can take to an appointment, which is how it works.

What is worth doing while you wait it out

There is no evidence-based protocol for shortening an IBS flare, and anyone selling you one is ahead of the data. What there is:

  • Change how you eat before what you eat. Portion size, meal spacing and fat load are levers that do not require you to eliminate anything. This is the core of traditional IBS dietary advice, which performed as well as low FODMAP over four weeks in a randomised comparison (Bohn 2015).
  • Protect sleep, specifically. It is one of the few things with a measured next-day effect in IBS (Jarrett 2000).
  • Keep moving if you can. The physical activity trial ran 12 weeks, so do not expect anything in a week, but the direction was clear and the intervention was simply being instructed to increase activity (Johannesson 2011).
  • Do not start a new elimination diet mid-flare. You will get false positives against everything, because a sensitised gut reacts to foods it normally tolerates.
  • Log the start date. Not to obsess, but because when it ends you will own one data point about your own duration, which is one more than the internet has.
  • Ask about second-line options if first-line has not worked. The BSG's IBS guideline reclassified IBS as a disorder of gut-brain interaction and sets out an evidence-graded framework of dietary, pharmacological and psychological options (Vasant 2021). A flare that has run for weeks is a legitimate reason to revisit the plan with your doctor.

Some of these overlap with things that help with cycle-related patterns, covered in why IBS gets worse around your period.

Myths about how long an IBS flare lasts

"The average IBS flare lasts two to four days." There is no such average, because there is no definition of a flare to average over. Every version of this number we traced led back to a page without a citation.

"If it has lasted more than a week it must be something else." Not supported. Plenty of people describe episodes lasting weeks, and the pretest probability of serious organic disease in people meeting IBS criteria is under 1% (Cash 2002). Long does not mean sinister. It does mean worth reviewing.

"A flare has to end on its own eventually." Not if the thing driving it has not stopped. Duration tracks the driver. That is also the hopeful reading: if you can identify and remove the driver, the episode has a reason to end.

"My IBS is getting worse every year, so it will keep getting worse." The long-term data does not support a steady decline as the default. In the systematic review of natural history, only 2 to 18 percent of people got worse over long-term follow-up (El-Serag 2004).

"Post-infectious IBS is permanent." Not for most people. Prevalence among the Walkerton cohort roughly halved between two to three years and eight years (Marshall 2010).

"Nothing helps, so there is no point trying anything." Also not supported, though the effect sizes are honest ones. In the network meta-analysis, peppermint oil ranked first for global symptom improvement, but no active treatment beat any other and most trials were not at low risk of bias (Black 2020). Modest, real, and worth a conversation.

"Worrying about it is just making it up." The gut-brain pathway is bidirectional and measured over 12 years in a population sample (Koloski 2012). Anxiety feeding symptoms does not make the symptoms imaginary.

When to see a doctor

Some symptoms should never be filed under "waiting out a flare". See a doctor promptly if you have any of the following:

  • Blood in your stool, or black, tarry stools
  • Unexplained weight loss
  • Fever alongside gut symptoms
  • Symptoms that wake you from sleep at night
  • Signs of anaemia, such as unusual breathlessness or fatigue
  • New bowel symptoms starting after the age of 50
  • A family history of bowel cancer, coeliac disease or inflammatory bowel disease
  • Symptoms that are clearly and persistently different in character from your usual pattern

Beyond the red flags, a few duration-specific triggers for booking an appointment:

  • Loose stools with increased frequency lasting more than four weeks, which meets the standard definition of chronic diarrhoea (Arasaradnam 2018)
  • A first-ever episode that has run for several weeks, especially if you have never been formally assessed
  • An episode that began with a documented gastrointestinal infection and has not improved
  • Symptoms that are stopping you eating adequately, working or leaving the house
  • A baseline that has shifted permanently rather than an episode that comes and goes

Bring dates. A clinician can do far more with "loose stools daily since 12 August, worse in the mornings, two stretches of severe pain" than with "it's been bad for a while".

The honest bottom line

How long does an IBS flare last? Nobody knows, and the reason nobody knows is that the question has never been made precise enough to answer. The literature measures weeks of response, not episodes. The one study we found with daily records suggests that what feels like a multi-day flare may be a cluster of short pain periods arriving close together, which is a more hopeful picture than one long block, and a more accurate one.

What you can do is stop looking for an average that does not exist and start collecting your own. Four episodes with start and end dates will tell you more about your next flare than every page on the first results screen combined. And if the four weeks pass without an end date to write down, that is not a longer flare. That is a different question, and it belongs with your doctor.

Frequently asked questions

How long do IBS flare ups last?
Nobody has published an average, because there is no agreed definition of when an IBS flare starts or ends. Most people describe bad patches lasting a few days to a couple of weeks, but that is lived experience rather than measured data. The best guide to your own duration is your own record of previous episodes.
Can an IBS flare up last for weeks?
Yes, and many people report exactly that. A long episode usually means the thing driving it has not stopped: an ongoing stressor, a diet that has not actually changed, disrupted sleep, or a gut that is still settling after an infection. Symptoms lasting more than four weeks meet the standard definition of chronic diarrhoea or chronic symptoms and are worth a medical review rather than more waiting.
How long does IBS pain last?
In the only study we found that recorded pain minute by minute, 59 people with IBS logged an average of 29 separate pain periods across 24 days of pain in six weeks, so individual pain episodes were short and repeated rather than one continuous block. That fits how most people describe it: waves rather than a wall.
How long does diarrhoea last with IBS?
IBS-related loose stools usually come in bouts rather than running continuously, and many people find they cluster in the morning. There is no published average. If loose or watery stools persist for more than four weeks, British Society of Gastroenterology guidance treats that as chronic diarrhoea needing investigation, not as a flare to ride out.
How often does IBS flare up?
It varies enormously and there is no typical frequency. Diary studies show symptoms fluctuating day to day while looking fairly stable when averaged over a fortnight, which is why the same person can honestly say both 'I flare every few weeks' and 'I am never really well'. Tracking for six to eight weeks usually reveals your own rhythm.
Is it normal for my first IBS flare to last a month or more?
It is very commonly reported. People in r/ibs describe first episodes lasting weeks to months, often because the diagnosis had not been made yet, the trigger was still in the diet, and anxiety about the unexplained symptoms was high. That is not evidence of a typical duration, but the pattern is consistent enough to be worth knowing. A first episode lasting weeks should be assessed by a doctor rather than waited out.
How long after changing my diet should a flare settle?
Trials of the low FODMAP diet used restriction periods of three to four weeks before judging the result, and both low FODMAP and standard IBS dietary advice reduced symptom scores over four weeks in a randomised comparison. A few days is rarely long enough to judge, and the restriction phase is meant to be short and structured, with reintroduction afterwards, ideally guided by a dietitian.
What counts as a flare if I have symptoms most days anyway?
A flare is a rise above your own baseline, not any day you do not feel completely well. If you define it as the second thing, the flare never ends and the word stops being useful. A baseline that is never acceptable is a separate problem, and it is one to take to a clinician rather than to manage as a long flare.
Does stress or worrying about it make a flare last longer?
The evidence points that way without proving it. A 12-year population study found anxiety predicted new gut symptoms and gut symptoms predicted new anxiety, so the arrow runs both ways. Pain catastrophising is more common in people with severe IBS symptoms than mild ones, and reductions in it during cognitive behavioural therapy tracked improvements in symptom severity.
How long does it take for IBS to go away?
IBS is usually described as a long-term, fluctuating condition rather than something that goes away on a schedule. A systematic review of long-term follow-up found roughly 30 to 50 percent of people had unchanged symptoms, 2 to 18 percent got worse, and the remainder improved or became symptom-free. Symptoms moving around over years is the normal pattern.

Sources

  1. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol. 1998;10(5):415-21. doi:10.1097/00042737-199805000-00011
  2. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-407.e5. doi:10.1053/j.gastro.2016.02.031
  3. Irvine EJ, Tack J, Crowell MD, Gwee KA, Ke M, Schmulson MJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1469-80.e1. doi:10.1053/j.gastro.2016.02.010
  4. El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;19(8):861-70. doi:10.1111/j.1365-2036.2004.01929.x
  5. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395-402. doi:10.1046/j.1365-2036.1997.142318000.x
  6. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128(3):580-9. doi:10.1053/j.gastro.2004.12.006
  7. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131(2):445-50. doi:10.1053/j.gastro.2006.05.053
  8. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605-11. doi:10.1136/gut.2009.202234
  9. Saha S, Sehgal K, Singh S, Grover M, Pardi D, Khanna S. Postinfection irritable bowel syndrome following Clostridioides difficile infection: a systematic review and meta-analysis. J Clin Gastroenterol. 2022;56(2):e84-93. doi:10.1097/MCG.0000000000001536
  10. Mathur A, Shams U, Mishra P, Sahu S, Goenka MK, Ghoshal U, et al. Post-infection irritable bowel syndrome following Coronavirus disease-19: a systematic review and meta-analysis. Indian J Gastroenterol. 2024;43(3):557-66. doi:10.1007/s12664-023-01486-x
  11. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284-90. doi:10.1136/gutjnl-2011-300474
  12. Priego-Parra BA, Reyes-Diaz SA, Ordaz-Alvarez HR, Martinez-Perez GP, Amieva-Balmori M, Garcia-Zermeno KR, et al. Gastrointestinal cognition: pain catastrophizing in irritable bowel syndrome, a cross-sectional study in Mexico. Neurogastroenterol Motil. 2025;37(7):e70022. doi:10.1111/nmo.70022
  13. Roger AH, Gudleski GD, Quigley BM, Zvolensky MJ, Lackner JM. Pain catastrophizing and clinical outcomes among patients receiving a novel cognitive-behavioral therapy for irritable bowel syndrome: an experimental therapeutics approach. Behav Ther. 2023;54(4):623-36. doi:10.1016/j.beth.2023.01.004
  14. Jarrett M, Heitkemper M, Cain KC, Burr RL, Hertig V. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci. 2000;45(5):952-9. doi:10.1023/A:1005581226265
  15. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75.e5. doi:10.1053/j.gastro.2013.09.046
  16. Bohn L, Storsrud S, Liljebo T, Collin L, Lindfors P, Tornblom H, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399-407.e2. doi:10.1053/j.gastro.2015.07.054
  17. Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036
  18. Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-40. doi:10.1136/gutjnl-2021-324598
  19. Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, et al. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(2):117-31. doi:10.1016/S2468-1253(19)30324-3
  20. Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402(10414):1773-85. doi:10.1016/S0140-6736(23)01523-4
  21. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32. doi:10.1056/NEJMoa1004409
  22. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003;52(11):1623-9. doi:10.1136/gut.52.11.1623
  23. Johannesson E, Simren M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011;106(5):915-22. doi:10.1038/ajg.2010.480
  24. Bosman M, Elsenbruch S, Corsetti M, Tack J, Simren M, Winkens B, et al. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(6):459-73. doi:10.1016/S2468-1253(21)00023-6
  25. Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018;67(8):1380-99. doi:10.1136/gutjnl-2017-315909
  26. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009;169(7):651-8. doi:10.1001/archinternmed.2009.22
  27. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30(7):707-17. doi:10.1111/j.1365-2036.2009.04081.x
  28. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol. 2002;97(11):2812-9. doi:10.1111/j.1572-0241.2002.07027.x

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Join the waitlist